Flowers Foods director exercises and receives stock awards
Flowers Foods director William Jameson McFadden reported compensation-related equity activity with no open-market buying or selling.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Flowers Foods director William Jameson McFadden reported compensation-related equity activity with no open-market buying or selling. He exercised 9,350 deferred stock units into an equal number of Common Stock shares at a stated price of $0.00 per share, bringing his directly held Common Stock to 648,131 shares. A new award of 22,260 Deferred Stock units, convertible into 22,260 Common Stock shares, was also granted under the company’s equity and incentive plans. Footnotes note that 460,383 of the directly held shares are in a trust for which he is the sole beneficiary and that totals include shares acquired through dividend reinvestment. He also reports indirect Common Stock holdings for a son and daughter of 1,363 shares and 2,993.152 shares, respectively.
Insights
Routine director equity grant and exercise with no sales reported.
Director William Jameson McFadden exercised 9,350 deferred stock units into Common Stock and received a new grant of 22,260 Deferred Stock units. Both transactions are recorded at a stated price of $0.00 per unit, typical for equity compensation awards.
The filing shows 648,131 Common Stock shares held directly after the exercise, including 460,383 shares in a trust where he is the sole beneficiary, plus smaller indirect holdings for a son and daughter. No open-market purchases or sales occur, so the economic signal is mainly that he continues to receive and retain equity-based compensation.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Deferred Stock | 9,350 | $0.00 | $0.00 |
| Grant/Award | Deferred Stock | 22,260 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,350 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (6)
- F1. Includes 460,383 shares held in a trust, of which the reporting person is the sole beneficiary.
- F2. Total includes shares acquired through reinvestment of dividends, based upon a statement dated 3/23/2026.
- F3. Granted under the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan (Amended and Restated Effective May 25, 2023).
- F4. In accordance with the terms of the Deferred Shares Agreement for Directors, the deferred shares awarded do not have a conversion or exercise price.
- F5. No expiration date.
- F6. Granted under the Flowers Foods, Inc. 2026 Equity and Incentive Compensation Plan.
Key Figures
Key Terms
Deferred Stock financial
2014 Omnibus Equity and Incentive Compensation Plan financial
2026 Equity and Incentive Compensation Plan financial
dividend reinvestment financial
trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity transactions did FLO director William McFadden report on this Form 4?
What Deferred Stock position does William McFadden report in this FLO Form 4?
Does the FLO Form 4 show any indirect holdings for William McFadden’s family?
Under which plans were William McFadden’s FLO Deferred Stock awards granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.